Group 1 - The core viewpoint of the article is that Sanbo Brain Science (301293.SZ) aims to enhance its business scale and core competitiveness by investing in a venture capital fund, thereby leveraging capital market advantages and professional investment management [1] - The company plans to subscribe to 87 million yuan worth of shares in the Shanghai Delian Bojian Venture Capital Partnership, which has a total fundraising target of 300 million yuan [1] - The investment is part of a strategy to improve the management of Sanbo Brain Science Hospital Management Group and to elevate the level of medical services [1]

Core Viewpoint - The announcement by Liao Co., Ltd. regarding the approval to invest up to 3 billion RMB in securities reflects an increasing market attractiveness and a gradual recovery of confidence among institutional and individual investors [1][2]. Group 1: Investment Principles - The company emphasizes the "main business first" principle, ensuring that funds are primarily allocated to core business needs to maintain long-term development [1][2]. - Building a professional investment team is crucial for successful investment decisions, as the complexity of the securities market requires high levels of expertise [2][3]. - Public companies must adhere strictly to legal boundaries during investment decisions to avoid regulatory penalties and protect shareholder interests [2][3]. Group 2: Risk Management - A balanced approach to risk and return is necessary, involving the establishment of a scientific risk-return assessment system and setting reasonable investment proportions based on risk tolerance [2][3]. - Companies should focus on long-term and value investment principles, avoiding speculative behaviors that could lead to unnecessary market volatility [3]. Group 3: Market Impact - The participation of listed companies in securities investment not only indicates enhanced market attractiveness but also injects vitality into the market, contributing to its stable development [3].